The Discounted Cash Flow (DCF) valuation of Medexus Pharmaceuticals Inc (MDP.V) is (30.79) CAD. With the latest stock price at 3.28 CAD, the upside of Medexus Pharmaceuticals Inc based on DCF is -1038.8%.
Based on the latest price of 3.28 CAD and our DCF valuation, Medexus Pharmaceuticals Inc (MDP.V) is a sell. selling MDP.V stocks now will result in a potential gain of 1038.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.5% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (159.37) - (17.85) | (30.79) |
| Upside | -4958.8% - -644.2% | -1038.8% |